Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Failure - NYHA II - IV”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Large-scale testing (Phase 3)Ended earlyNCT00679484
What this trial is testing

Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24

Who this might be right for
Chronic Heart FailureHigh Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 400
Not applicableStudy completedNCT04862273
What this trial is testing

CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IV+4 more
University of Leipzig 112
Not applicableNot Yet RecruitingNCT07046091
What this trial is testing

Effects of a 20-Minute Mindfulness-Based Breathing Exercise on Dyspnea, Fatigue, and Sleep Quality in Patients With Heart Failure

Who this might be right for
Heart FailureHeart Failure - NYHA II - IV
Firat University 72
Large-scale testing (Phase 3)Looking for participantsNCT06935370
What this trial is testing

Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Who this might be right for
Heart Failure
Boehringer Ingelheim 4,200
Not applicableUnknownNCT05487365
What this trial is testing

Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF

Who this might be right for
Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III+1 more
Comunicare Solutions SA 330
Large-scale testing (Phase 3)Study completedNCT00853658
What this trial is testing

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 7,064
Not applicableStudy completedNCT01097733
What this trial is testing

Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy

Who this might be right for
Heart Failure - NYHA II - IVWide QRS Complex
Massachusetts General Hospital 38
Not applicableWithdrawnNCT03947853
What this trial is testing

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure

Who this might be right for
Heart FailureHeart Failure NYHA Class IIIHeart Failure NYHA Class II+1 more
Elpen Pharmaceutical Co. Inc.
Not applicableNot Yet RecruitingNCT07709208
What this trial is testing

Mitral Valve Edge-to-Edge Repair in Patients With Exercise-Induced Severe Mitral Regurgitation

Who this might be right for
Heart Failure - NYHA II - IVMitral Regurgitation Functional
Jena University Hospital 246
Large-scale testing (Phase 3)Study completedNCT04435626
What this trial is testing

Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

Who this might be right for
Heart Failure
Bayer 6,016
Not applicableStudy completedNCT03895073
What this trial is testing

HEart fAiluRe evaluaTion Questionnaire

Who this might be right for
Heart FailureHeart Failure NYHA Class IIIHeart Failure NYHA Class II+2 more
John Parissis 170
Testing effectiveness (Phase 2)Ended earlyNCT00283361
What this trial is testing

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Who this might be right for
Heart Failure, Congestive
Zealand Pharma 130
Not applicableNot Yet RecruitingNCT07205679
What this trial is testing

Cardiovascular Performance and Exercise Response in Patients With Persistent or Permanent Atrial Fibrillation and Heart Failure Pre and Post Cardioversion or Pace and Ablate

Who this might be right for
Atrial Fibrillation (AF)Heart Failure - NYHA II - IVPacemaker+2 more
Habib Khan 40
Post-approval studies (Phase 4)Looking for participantsNCT07263035
What this trial is testing

Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure

Who this might be right for
Heart FailureHeart Failure - NYHA II - IVHeart Failure Acute+1 more
Lakeland Regional Health Systems, Inc. 600
Large-scale testing (Phase 3)Ended earlyNCT03909295
What this trial is testing

An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Novartis Pharmaceuticals 52
Not applicableStudy completedNCT06270875
What this trial is testing

Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)

Who this might be right for
Chronic IllnessNYHA Class II-IV Heart Failure
University of Alabama at Birmingham 10
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Testing effectiveness (Phase 2)UnknownNCT05336175
What this trial is testing

Biomarker Study: Heart Failure Patients at Risk

Who this might be right for
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
University of Arizona 40
Not applicableEnrolling By InvitationNCT07775976
What this trial is testing

Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways

Who this might be right for
Cardiovascular DiseasesCardiovascular Diseases RiskCardiac Conduction System Disease+21 more
Peerbridge Health, Inc 1,000
Not applicableLooking for participantsNCT07222813
What this trial is testing

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Who this might be right for
Heart FailureHeart Failure - NYHA II - IV
Echosens 149
Next Page